Survivalover 6 years in a patient with brain metastases from melanoma treated with temozolomide

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Koekkoek, Johan A F ^a   Wiggenraad, Ruud G ^b   Zwinkels, Hanneke ^a   Taphoorn, Martin J B ^a   Oosterkamp, Rianne M ^a  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b Radiotherapy Center West   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; TEMOZOLOMIDE;

ADULT; AGRAPHIA; APRAXIA; ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; CRANIOPLASTY; CRANIOTOMY; DIZZINESS; DYSCALCULIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIQUORRHEA; LUNG METASTASIS; MEDICAL HISTORY; MELANOMA; MULTIPLE CYCLE TREATMENT; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; TREATMENT OUTCOME; WALKING DIFFICULTY; WEAKNESS;

EID: 84870432456     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-007087     Document Type: Article

References (7)

1. Amer MH, Al-Sarraf M, Baker LH, et al. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978; 42:660 -8.
2. Sampson JH, Carter JH Jr, Friedman AH, et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998;88:11-20. (Pubitemid 28018958)
3. Bottoni U, Bonaccorsi P, Devirgiliis V, et al. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF. Jpn J Clin Oncol 2005;35 :507-13. (Pubitemid 41573939)
4. Raizer JJ, Hwu WJ, Panageas KS, et al. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol 2008;10:199-207.
5. Boogerd W, de Gast GC, Dalesio O. Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation? Cancer 2007; 109:306-12. (Pubitemid 46106245)
6. Margolin K, Ernstoff MS, Hamid O, et al. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. Lancet Oncol 2012;13:459-65.
7. Agarwala SS, Kirkwood JM, Gore M, et al. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 2004;22:2101-7. (Pubitemid 41095143)